The Psychedelic Drug Development Pipeline

In early 2023, we visualised our Psychedelics Drug Development Tracker data in a ‘bullseye chart’ format as part of 2022’s Year in Review. Due to its popularity, Noah Smith and Michael Haichin have once again prepared a bullseye chart of the psychedelic drug development pipeline, as it stood at the end of 2023.

Given the number of candidates included, we recommend downloading a PDF of the tracker for a better viewing experience. More info below the image.

Download a PDF Copy of the Chart

If you would like to receive a high-resolution PDF of the bullseye chart, please enter your email below. You may also opt-in to our newsletter by checking the box.

Stay Informed in 2024 with Pα+

This resource, which is part of our 2023 Year in Review, is free to access. Subscribe to Pα+ to receive all of our Bulletins, deep dives and analysis, as well as access to the Pα+ Library and other subscriber-only content.

Your subscription goes directly toward supporting our coverage, not glossy graphic design or marketing budgets. Learn more and subscribe here, or get in touch to discuss team plans.